J.P. Morgan Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating

Moomoo NewsDec 14 09:32 ET · Ratings

Neurocrine Wins FDA Nod for CAH Therapy

Seeking AlphaDec 14 07:45 ET

Express News | Neurocrine Biosciences Inc - Crenessity Expected to Be Available in One Week

ReutersDec 13 18:56 ET

Express News | FDA: Crenessity Approved as Adjunctive Treatment for Adults & Pediatric Patients 4 Years of Age & Older With Classic Congenital Adrenal Hyperplasia

ReutersDec 13 17:45 ET

Express News | FDA Approves Neurocrine Biosciences' Crenessity- Website

ReutersDec 13 17:41 ET

FDA Approves New Treatment for Congenital Adrenal Hyperplasia

US FDADec 12 19:00 ET